Published Application/Species/Sample/Dilution | Reference |
---|---|
| |
| Man Kupisinska A, Michalski M, Maciejewska A, Swierzko A, Cedzynski M, Lugowski C, et al. A New Ligand-Based Method for Purifying Active Human Plasma-Derived Ficolin-3 Complexes Supports the Phenomenon of Crosstalk between Pattern-Recognition Molecules and Immunoglobulins. PLoS ONE. 2016;11:e0156691 pubmed publisher
|
| |
| |
Lacroix M, Dumestre Pérard C, Schoehn G, Houen G, Cesbron J, Arlaud G, et al. Residue Lys57 in the collagen-like region of human L-ficolin and its counterpart Lys47 in H-ficolin play a key role in the interaction with the mannan-binding lectin-associated serine proteases and the collectin receptor calreticulin. J Immunol. 2009;182:456-65 pubmed
| |
Honore C, Hummelshoj T, Hansen B, Madsen H, Eggleton P, Garred P. The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells. Arthritis Rheum. 2007;56:1598-607 pubmed
| |
Wang C, Yim K, Poon T, Choy K, Chu C, Lui W, et al. Innate immune response by ficolin binding in apoptotic placenta is associated with the clinical syndrome of preeclampsia. Clin Chem. 2007;53:42-52 pubmed
| |
Terai I, Kobayashi K, Vaerman J, Mafune N. Degalactosylated and/or denatured IgA, but not native IgA in any form, bind to mannose-binding lectin. J Immunol. 2006;177:1737-45 pubmed
| |
Imai N, Nishi S, Alchi B, Ueno M, Fukase S, Arakawa M, et al. Immunohistochemical evidence of activated lectin pathway in kidney allografts with peritubular capillary C4d deposition. Nephrol Dial Transplant. 2006;21:2589-95 pubmed
| |
Krarup A, Sørensen U, Matsushita M, Jensenius J, Thiel S. Effect of capsulation of opportunistic pathogenic bacteria on binding of the pattern recognition molecules mannan-binding lectin, L-ficolin, and H-ficolin. Infect Immun. 2005;73:1052-60 pubmed
|
5405 PB UDEN
Hycult Biotech’s mission and strategy is to advance insight in innate immunity related diseases, for the benefit of individuals and their quality of life.
As a leader within focused fields of immunology and cell biology, we develop products for the life sciences and in accordance with our mission it is our ambition to facilitate the transition of these products from research use into diagnostic testing. Many of our reagents are developed in close cooperation with scientists worldwide. Hycult Biotech has built a strong network with over 40 close scientific collaborations with leading international research institutes. We contribute to numerous projects and as a result, can continuously offer early access to an expanding range of innovative reagents. Hycult Biotech has been ISO-9001 certified since 1998 and we upgraded our certification to ISO-13485 in 2007, with a milestone of our first release of CE marked assays in 2009. Our vision, knowledgeable team and quality management system guarantee products of the highest grade combined with excellent technical service.